Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Even after Trump’s new deal, obesity drugs are still too expensive.

WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand ...

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

President Trump appeared in the oval office with executives from the companies behind GLP1 weight loss drug Wegovy and ...

Trump announced that his administration reached a deal with Novo Nordisk and Eli Lilly to lower the price of Ozempic and ...

The deal is with both Eli Lilly and Novo Nordisk, and is expected to lower the price of obesity drugs to $149 per month in some cases ...

“The lowest price, of $150 a month, will be available only for the lowest doses of the pill form of the drugs. When those drugs reach the market, Medicare and Medicaid will pay that price, as will ...

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

The Trump administration announced deals with Novo Nordisk and Lilly to sell their weight loss products at a discounted rate ...

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity ...